TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 9.06
+0.05 (0.55%)
May 29, 2026, 1:30 PM CST
TPEX:4157 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 53.51 | 45.18 | -38.58 | 136.73 | -237.16 | 775.62 |
Depreciation & Amortization | 14.02 | 17.37 | 24.77 | 27.48 | 28.46 | 28.74 |
Other Amortization | 0.11 | 0.11 | 0.06 | 0.13 | 0.09 | 0.12 |
Loss (Gain) From Sale of Assets | -1.45 | -1.45 | - | - | - | 0.08 |
Asset Writedown & Restructuring Costs | 0.74 | 0.74 | 1.96 | - | 12.06 | - |
Loss (Gain) From Sale of Investments | -0.76 | -2.47 | -13.55 | -165.22 | -0.3 | -0.08 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 23.24 |
Stock-Based Compensation | -0.49 | -11.63 | 32.48 | 25 | -4.99 | 40.03 |
Provision & Write-off of Bad Debts | - | - | - | 7.6 | - | - |
Other Operating Activities | 2.03 | 6.3 | -63.1 | 1.22 | -60.88 | 40.07 |
Change in Accounts Receivable | 2.53 | 2.33 | 1.65 | 1.83 | 260.02 | -272.8 |
Change in Inventory | -21.12 | -33.39 | -8.24 | -18.75 | 3.29 | -4.35 |
Change in Accounts Payable | -1.11 | 0.64 | 1.96 | 0.66 | -17.33 | 10.49 |
Change in Unearned Revenue | 6.25 | -0.15 | -0.15 | -0.15 | -0.16 | -44.41 |
Change in Income Taxes | - | - | - | - | - | 26.29 |
Change in Other Net Operating Assets | 5.52 | 7.39 | 3.37 | -9.05 | -4.37 | -2.68 |
Operating Cash Flow | 64.82 | 20.93 | -173.09 | 7.46 | -21.27 | 629.07 |
Capital Expenditures | -1.55 | -1.45 | -0.53 | -3.89 | -3.39 | -10.24 |
Sale of Property, Plant & Equipment | 6.64 | 6.64 | - | - | - | 0.11 |
Sale (Purchase) of Intangibles | -20.21 | -3.06 | -2.16 | -3.51 | -4.07 | -1.6 |
Investment in Securities | 63.26 | 58.14 | -136.22 | 138.44 | -81.62 | -298.07 |
Other Investing Activities | 19.38 | 23.09 | 28.04 | 14.42 | 4.13 | 3.73 |
Investing Cash Flow | 67.52 | 83.37 | -110.87 | 145.46 | -84.95 | -306.07 |
Short-Term Debt Issued | - | 35 | - | - | 3 | - |
Total Debt Issued | - | 35 | - | - | 3 | - |
Short-Term Debt Repaid | - | - | - | -3 | - | - |
Long-Term Debt Repaid | - | -10.7 | -15.98 | -16.99 | -17.99 | -18.61 |
Total Debt Repaid | -43.04 | -10.7 | -15.98 | -19.99 | -17.99 | -18.61 |
Net Debt Issued (Repaid) | -43.04 | 24.3 | -15.98 | -19.99 | -14.99 | -18.61 |
Repurchase of Common Stock | -57.28 | -57.28 | - | - | - | - |
Other Financing Activities | -1.43 | -1.67 | -1.42 | -1.14 | -0.85 | -0.24 |
Financing Cash Flow | -101.74 | -34.64 | -17.4 | -21.12 | -15.84 | -18.85 |
Foreign Exchange Rate Adjustments | 2.68 | 1.29 | 0.84 | -0.25 | 0.24 | -0.07 |
Net Cash Flow | 33.27 | 70.95 | -300.52 | 131.55 | -121.82 | 304.08 |
Free Cash Flow | 63.27 | 19.48 | -173.62 | 3.57 | -24.66 | 618.83 |
Free Cash Flow Margin | 24.43% | 7.51% | -115.25% | 2.90% | -68.06% | 47.80% |
Free Cash Flow Per Share | 0.09 | 0.03 | -0.24 | 0.01 | -0.03 | 0.86 |
Cash Interest Paid | 1.67 | 1.67 | 1.42 | 1.14 | 0.85 | 0.24 |
Cash Income Tax Paid | 12.37 | 12.37 | 5.1 | 9.83 | 32.22 | 72.51 |
Levered Free Cash Flow | 25.25 | 29.5 | -18.62 | -84.51 | 57.08 | 366.39 |
Unlevered Free Cash Flow | 26.14 | 30.54 | -17.73 | -83.8 | 57.61 | 366.55 |
Change in Working Capital | -2.88 | -33.21 | -117.13 | -25.47 | 241.45 | -278.76 |